Infliximab downregulates interferon-γ production in activated gut T-lymphocytes from patients with Crohn's disease

Cytokine

Volumn 15, Issue 4, 2001, Pages 212-222

  Agnholt, Jørgen ^a,b   Kaltoft, Keld ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Infliximab; Interferon ; T cells; Transmembrane TNF

Indexed keywords

AZATHIOPRINE; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 2; INTERLEUKIN 4; MESALAZINE; NEUTRALIZING ANTIBODY; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOLYSIS; DISEASE ACTIVITY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035928895     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0919     Document Type: Article

References (23)

1. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
2. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease
3. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers
4. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cell
5. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease
6. Immunomodulation of Crohn's disease using TNF-a neutralizing monoclonal antibodies
7. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
8. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease
9. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
10. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
11. Infliximab for the treatment of fistulas in patients with Crohn's disease
12. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions
13. Anti-TNF antibody Ca2 induces apoptosis in CD3/CD28 stimulated Jurkat Cells; a potent immunomodulating mechanism
14. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells
15. Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines
16. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
17. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway
18. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
19. Spontaneous secretion of interferon gamma and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes
20. Just how inflamed is the normal gut?
21. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation
22. Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines
23. In vitro genetically aberrant T-cell clones with continuous growth are associated with atopic dermatitis